FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Grants Threshold Pharma Fast Track for Sarcoma Drug

[ Price : $8.95]

FDA grants Threshold Pharmaceuticals a fast track designation for TH-302, an investigational anticancer drug for treating previous...

QS Violations Found in Mani Hanoi Inspection

[ Price : $8.95]

FDA warns Vietnams Mani Hanoi Co. about QS regulation violations in its manufacturing of surgical sutures with attached needles.

Experts Question Anti-depressant Boxed Warning

[ Price : $8.95]

Time magazine says psychiatrists differ on whether antidepressants should continue to carry a Boxed Warning about suicidality in c...

FDA Clears Medicrea Groups Spinal Rod

[ Price : $8.95]

FDA clears a Medicrea Group 510(k) for its UNiD, a patient-specific spinal osteosynthesis rod.

FDA Clears Titan Spine Interbody Fusion Implant

[ Price : $8.95]

FDA clears a Titan Spine 510(k) for its Endoskeleton line of interbody fusion implants featuring its next-generation nanoLOCK surf...

FDA Proposing Rigid Pedicle Screw Reclassification

[ Price : $8.95]

FDA proposes to reclassify the rigid pedicle screw system from Class 3 to Class 2 with special controls.

GliaCure Gains Fast Track for Alzheimers Therapy

[ Price : $8.95]

FDA grants GliaCure a fast track designation for its lead product candidate for Alzheimer's disease, GC021109.

Latest FDA Warning Letters

[ Price : $8.95]

In its latest batch of Warning Letters, FDA cites Abler, Keith A. Aqua, Cadila Pharmaceuticals, Cox Veterinary Laboratory, Electro...

Comments Sought on DTC Drug Ad Research

[ Price : $8.95]

Federal Register Notice: FDA seeks comments on research on the impact of variation in ad exposure frequency on perception and ment...

Guidance on Diagnostic Instruments with Combined Functions

[ Price : $8.95]

Federal Register Notice: FDA releases a guidance: Molecular Diagnostic Instruments with Combined Functions.